BlackRock Japan’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

BlackRock Japan’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,731	Closed	-$14K	–	1557
2016 Q1	$14K	Buy	1,731 +394	+29%	+$2.97K	﹤0.01%	1242
2015 Q4	$13K	Sell	1,337 -164	-11%	-$1.7K	﹤0.01%	1242
2015 Q3	$14K	Buy	+1,501	New	+$21.1K	﹤0.01%	1138
2014 Q3	–	Sell	-246	Closed	-$15K	–	1376
2014 Q2	$15K	Buy	+246	New	+$15K	﹤0.01%	1182

Other funds holding TBRA

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

BlackRock Japan's TBRA Position: Q2 2016 in Review

BlackRock Japan sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q2 2016, closing a stake of 1,731 shares — an estimated $14K sold.

BlackRock Japan first reported a position in TBRA in Q2 2014 and held it in 4 quarters. The position peaked at $15K in Q2 2014. 45 funds tracked by Wall St. Rank hold TBRA as of Q2 2016.

BlackRock Japan reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
BlackRock Japan sold 1,731 Tobira Therapeutics, Inc. Common Stock shares in Q2 2016, an estimated $14K.
BlackRock Japan first reported a position in Tobira Therapeutics, Inc. Common Stock in Q2 2014 and held it in 4 quarters.
BlackRock Japan's Tobira Therapeutics, Inc. Common Stock position peaked at $15K in Q2 2014.
45 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q2 2016.

Based on BlackRock Japan's 13F filing for Q2 2016, filed 10 Aug 2016.